NASDAQ:SERA Sera Prognostics Q3 2026 Earnings Date & Estimates $2.04 +0.01 (+0.49%) Closing price 04:00 PM EasternExtended Trading$2.02 -0.02 (-0.98%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sera Prognostics is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sera Prognostics in Q3 2026Sera Prognostics is expected to post earnings of -$0.14 per share on revenue of $75 thousand. In the same quarter a year earlier Sera Prognostics reported -$0.16 per share on revenue of $16 thousand. Sera Prognostics last reported on August 12, 2026, posting -$0.18 per share and missing the -$0.1542 consensus estimate. Sera Prognostics has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.14Expected Revenue$75 thousandPrior-Year EPS-$0.16Prior-Year Revenue$16 thousandExpected Revenue Growth+368.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.18 (Missed by -$0.0258)Last Quarter Revenue$30 thousandEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Sera Prognostics Q3 2026 Earnings FAQ When does Sera Prognostics report Q3 2026 earnings? Sera Prognostics (NASDAQ:SERA) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Sera Prognostics' Q3 2026 earnings call? Sera Prognostics' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sera Prognostics? Analysts expect Sera Prognostics to post earnings of -$0.14 per share for Q3 2026. How much revenue is Sera Prognostics expected to report? The consensus revenue estimate for Sera Prognostics is $75 thousand for Q3 2026. Sera Prognostics Earnings HeadlinesSERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026October 21, 2026 | prnewswire.comNeuphoria Therapeutics (NASDAQ:NEUP) vs. Sera Prognostics (NASDAQ:SERA) Financial SurveyOctober 21, 2026 | americanbankingnews.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.October 26 at 1:00 AM | Brownstone Research (Ad)Reviewing Sera Prognostics (NASDAQ:SERA) and TScan Therapeutics (NASDAQ:TCRX)October 20, 2026 | americanbankingnews.comComparing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)October 19, 2026 | americanbankingnews.comSera Prognostics, Inc.(NasdaqGM:SERA) dropped from S&P Global BMI IndexSeptember 20, 2026 | marketscreener.comMSee More Sera Prognostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sera Prognostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sera Prognostics and other key companies, straight to your email. Email Address About Sera PrognosticsSera Prognostics (NASDAQ:SERA) is a women’s health diagnostics company focused on improving pregnancy outcomes through biomarker-based testing. The company uses proteomics, bioinformatics and clinical data to develop diagnostic and prognostic products designed to identify risks associated with pregnancy complications. Its lead product is the PreTRM test, a blood-based test intended to assess a pregnant woman’s risk of spontaneous preterm birth in a singleton pregnancy. The test measures specific protein biomarkers and is designed to provide physicians with information that may support risk assessment, patient management and care planning during pregnancy. Founded in 2008 and headquartered in Salt Lake City, Utah, Sera Prognostics primarily serves the U.S. healthcare market. In addition to PreTRM, the company is developing additional diagnostic products aimed at conditions affecting maternal and fetal health, including other pregnancy-related complications. Sera Prognostics trades on the Nasdaq under the symbol SERA.View Sera Prognostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
